Meihua International Medical Technologies Co., Ltd. (MHUAF)
OTCMKTS · Delayed Price · Currency is USD
10.00
+1.01 (11.23%)
At close: Feb 18, 2026
MHUAF Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 89.55 | 96.91 | 97.1 | 103.35 | 104.04 | 89.06 | |
Revenue Growth (YoY) | -4.99% | -0.19% | -6.04% | -0.66% | 16.82% | 11.85% |
Cost of Revenue | 58.89 | 63.7 | 64 | 65.38 | 64.36 | 52.05 |
Gross Profit | 30.66 | 33.21 | 33.1 | 37.97 | 39.68 | 37.01 |
Selling, General & Admin | 12.43 | 13.7 | 13.15 | 18.81 | 10.69 | 11.05 |
Research & Development | 3.33 | 3.46 | 2.75 | 2.96 | 2.73 | 2.49 |
Other Operating Expenses | 0.63 | 0.63 | 0.59 | 0.64 | - | - |
Operating Expenses | 19 | 18.89 | 18.42 | 22.41 | 13.42 | 13.54 |
Operating Income | 11.66 | 14.31 | 14.67 | 15.56 | 26.26 | 23.47 |
Interest Expense | -1.5 | -1.51 | -0.25 | -0.19 | -0.18 | -0.14 |
Interest & Investment Income | 1.3 | 1.01 | 0.87 | 0.06 | 0.02 | 0.04 |
Currency Exchange Gain (Loss) | 0.08 | 0.38 | -0.15 | 0.27 | 0.17 | 0.39 |
Other Non Operating Income (Expenses) | 0.18 | 0.1 | -0.1 | -0.05 | -0.05 | -0.03 |
EBT Excluding Unusual Items | 11.71 | 14.3 | 15.05 | 15.65 | 26.23 | 23.73 |
Other Unusual Items | -0.16 | -0.68 | - | -4.76 | - | - |
Pretax Income | 11.54 | 13.63 | 15.05 | 10.89 | 26.23 | 23.73 |
Income Tax Expense | 2.27 | 2.79 | 3.46 | 4.71 | 5.28 | 4.69 |
Earnings From Continuing Operations | 9.27 | 10.84 | 11.59 | 6.18 | 20.95 | 19.05 |
Minority Interest in Earnings | 0 | 0.01 | 0.03 | 0.07 | - | - |
Net Income | 9.27 | 10.84 | 11.63 | 6.24 | 20.95 | 19.05 |
Net Income to Common | 9.27 | 10.84 | 11.63 | 6.24 | 20.95 | 19.05 |
Net Income Growth | -0.09% | -6.73% | 86.22% | -70.20% | 10.00% | 23.42% |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 12.69% | 14.34% | 2.26% | 17.06% | - | 7.67% |
EPS (Basic) | 30.11 | 39.62 | 48.56 | 26.67 | 104.75 | 95.23 |
EPS (Diluted) | 28.96 | 39.62 | 48.56 | 26.67 | 104.75 | 95.23 |
EPS Growth | -20.95% | -18.42% | 82.10% | -74.54% | 10.00% | 14.63% |
Free Cash Flow | 3.59 | 14.5 | 1.09 | -11.86 | -0.9 | -10.79 |
Free Cash Flow Per Share | 11.64 | 52.99 | 4.57 | -50.67 | -4.52 | -53.97 |
Gross Margin | 34.24% | 34.27% | 34.08% | 36.74% | 38.14% | 41.55% |
Operating Margin | 13.02% | 14.77% | 15.11% | 15.05% | 25.24% | 26.35% |
Profit Margin | 10.35% | 11.19% | 11.97% | 6.04% | 20.14% | 21.39% |
Free Cash Flow Margin | 4.00% | 14.97% | 1.13% | -11.48% | -0.87% | -12.12% |
EBITDA | 12.21 | 14.88 | 15.15 | 16.12 | 26.88 | 23.99 |
EBITDA Margin | 13.64% | 15.36% | 15.60% | 15.60% | 25.84% | 26.94% |
D&A For EBITDA | 0.55 | 0.57 | 0.47 | 0.56 | 0.62 | 0.52 |
EBIT | 11.66 | 14.31 | 14.67 | 15.56 | 26.26 | 23.47 |
EBIT Margin | 13.02% | 14.77% | 15.11% | 15.05% | 25.24% | 26.35% |
Effective Tax Rate | 19.68% | 20.47% | 22.98% | 43.28% | 20.13% | 19.75% |
Revenue as Reported | 89.55 | 96.91 | 97.1 | 103.35 | 104.04 | 89.06 |
Advertising Expenses | - | 0 | 0.01 | 0.1 | 0.02 | 0.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.